Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01911598
What this trial is testing

MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

Who this might be right for
Head and Neck Cancer
Genentech, Inc. 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06989671
What this trial is testing

SYS6002 Plus JMT101 and Enlonstobart Injection in Participants With HNSCC

Who this might be right for
Head and Neck Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 430
Testing effectiveness (Phase 2)Active Not RecruitingNCT04843098
What this trial is testing

Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Suzhou Junde Biotechnology Co., Ltd 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07744126
What this trial is testing

Assess Adverse Events, Change in Disease Activity and Optimal Dose of Intravenous (IV) Telisotuzumab Adizutecan With IV Pembrolizumab for First-Line Treatment of Adult Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
AbbVie 150
Early research (Phase 1)UnknownNCT05552807
What this trial is testing

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Carcinoma
Sinocelltech Ltd. 120
Testing effectiveness (Phase 2)WithdrawnNCT05359692
What this trial is testing

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic Head and Neck Squamous Cell CarcinomaAdvanced MalignanciesRecurrent Head and Neck Squamous Cell Carcinoma
Incyte Biosciences International Sàrl
Early research (Phase 1)WithdrawnNCT00492947
What this trial is testing

Dendritic Cell Vaccine for Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
University of Maryland, Baltimore
Testing effectiveness (Phase 2)Study completedNCT00705016
What this trial is testing

Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Who this might be right for
Squamous Cell Cancer
Merck KGaA, Darmstadt, Germany 184
Testing effectiveness (Phase 2)UnknownNCT01527877
What this trial is testing

Study of BKM120 in Advanced Squamous Cell Carcinoma of Head and Neck

Who this might be right for
Head Neck Cancer Squamous Cell MetastaticHead Neck Cancer Squamous Cell Recurrent
Yonsei University 53
Large-scale testing (Phase 3)Study completedNCT01156142
What this trial is testing

Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy

Who this might be right for
Head and Neck CancerMucositisOral Complications of Radiation Therapy+1 more
Alliance for Clinical Trials in Oncology 155
Testing effectiveness (Phase 2)Ended earlyNCT02521870
What this trial is testing

A Trial of Intratumoral Injections of SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma or Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Metastatic MelanomaHead Neck Cancer
Dynavax Technologies Corporation 241
Large-scale testing (Phase 3)Study completedNCT02741570
What this trial is testing

Study of Nivolumab in Combination With Ipilimumab Compared to the Standard of Care (Extreme Regimen) as First Line Treatment in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Bristol-Myers Squibb 947
Testing effectiveness (Phase 2)Study completedNCT01864772
What this trial is testing

Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastatic HNSCC

Who this might be right for
Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Groupe Oncologie Radiotherapie Tete et Cou 85
Testing effectiveness (Phase 2)Study completedNCT00639769
What this trial is testing

Irinotecan and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT04815720
What this trial is testing

Pepinemab in Combination With Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Vaccinex Inc. 49
Testing effectiveness (Phase 2)Study completedNCT02762513
What this trial is testing

Expansion Trial for Axitinib In Head And Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Michigan Rogel Cancer Center 29
Testing effectiveness (Phase 2)Study completedNCT00004070
What this trial is testing

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 7
Large-scale testing (Phase 3)Active Not RecruitingNCT06525220
What this trial is testing

Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Merus B.V. 699
Testing effectiveness (Phase 2)Study completedNCT03818061
What this trial is testing

Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Neoplasms
Centre Leon Berard 33
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Next Page